Novartis provides healthcare solutions that improve and extend people's lives. We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Our company is focused on industry-leading divisions with innovation power and global scale: pharmaceuticals, eye care and generic medicinesNovartis is headquartered in Basel, Switzerland. Novartis Group companies employ approximately 120,000 associates and its products are available in more than 180 countries around the world. See our community guidelines:
57
Total Investments
44
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biotechnology, Digital Health +1
Funding Stage
Seed
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Novartis
Recent Investments (57)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Late Vc | •••••• | Dec 2025 | |
| Post Ipo Equity | •••••• | Oct 2025 | |
| Post Ipo Equity | •••••• | Sep 2025 | |
| Acquisition | •••••• | Sep 2025 | |
| Acquisition | •••••• | Feb 2025 | |
|
|
Acquisition | •••••• | Nov 2024 |
|
|
Late Vc | •••••• | Jul 2024 |
|
|
Post Ipo Equity | •••••• | Feb 2024 |
|
|
Venture Round | •••••• | Dec 2023 |
|
|
Series B | •••••• | Jul 2023 |
Latest News
The company that built TikTok’s algorithm is now designing drugs for diseases pharma called undruggable
Thenextweb · May 02, 2026
Demis Hassabis says Google DeepMind had to return to its startup roots after the Brain merger
Thenextweb · Apr 09, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.